THE VIEW FROM HERE

New Hepatitis C Drug, Old Problems
By Christopher F. Koller
President of the Milbank Memorial Fund

Every once in a while, an issue comes along that serves up so clearly the conflict between a societal desire to maximize medical care treatment choices and the reality of limited resources that people say, “Maybe this is the one that will provoke the hard conversations.” Enter Sovaldi for the treatment of Hepatitis C.

READ MORE

NEW: Milbank Issue Brief featured in FierceHealthPayer: 3 Ways to Align Quality Goals Across Payers

Milbank Quarterly study featured in the LA Times: Tobacco Industry Once Had High Hopes for Marijuana Business and Time: Big Tobacco Planned Big Marijuana Sales in the 1970s

Milbank Quarterly study featured in MedicalExpress: Class and Insurance Stigma are Barriers to Good Health Care

From Howard Markel, Editor-in-Chief of The Milbank Quarterly: How Dr. Heimlich Got His Maneuver 40 Years Ago

READ MORE

Effective Public Management of Mental Health Care:
Views from States on Medicaid Reforms That Enhance Service Integration and Accountability
   Bookmark and Share
Co-published with the Bazelon Center for Mental Health Law
2000 
HTML

CURRENT ISSUE

June 2014 (Volume 92, Number 2)
Table of Contents

Current Featured Article

Waiting for the Opportune Moment: The Tobacco Industry and Marijuana Legalization
Rachel Ann Barry, Heikki Hiilamo, Stanton A. Glantz

GO TO QUARTERLY PAGE

LATEST REPORT

Health Worker Shortages and Global Justice   
Paula O'Brien and Lawrence O. Gostin
2011

 

GO TO REPORTS PAGE

RECENT BOOK

Lead Wars: The Politics of Science and the Fate of America's Children
Gerald Markowitz and David Rosner
2013


GO TO BOOKS PAGE